| 000 | 01185cam a22002778i 4500 | ||
|---|---|---|---|
| 005 | 20200314100523.0 | ||
| 008 | 150407s2015 xxu 000 0 eng | ||
| 020 | _a9781118788356 (empastado, cubierta dura) | ||
| 035 | _aMX001001701529 | ||
| 040 |
_aDNLM/DLC _bspa _cDLC _dUNAMX _erda |
||
| 050 | 0 |
_aRM315 _bB554 |
|
| 082 | 0 | 0 |
_a615.7/8 _223 |
| 245 | 0 | 0 |
_aBlood-brain barrier in drug discovery : _boptimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs / _cedited by Li Di, Edward H. Kerns |
| 264 | 1 |
_aHoboken, New Jersey : _bJ. Wiley & Sons Inc., _c[2015] |
|
| 264 | 1 | _c©2015 | |
| 300 | _a586 páginas | ||
| 650 | 1 | 4 |
_aBarrera hematoencefálica _xMetabolismo |
| 650 | 1 | 4 |
_aAgentes del sistema nervioso central _xFarmacologia |
| 700 | 1 |
_aDi, Li, _eeditor de la compilación |
|
| 700 | 1 |
_aKerns, Edward Harvel, _eeditor de la compilación |
|
| 776 | 0 | 8 |
_iVersion en línea: _tBlood-brain barrier in drug discovery _dHoboken, New Jersey : John Wiley & Sons Inc., [2015] _z9781118788493 _w(DLC) 2014041569 |
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 999 |
_c13925 _d13925 |
||